|
NAP1L1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.90729987359362E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.40480000357479E-08 |
| Normal-vs-Stage2 |
4.384500E-03 |
| Normal-vs-Stage3 |
5.19859999492667E-08 |
| Normal-vs-Stage4 |
5.18189999798579E-08 |
| Stage1-vs-Stage2 |
3.416400E-01 |
| Stage1-vs-Stage3 |
4.276200E-01 |
| Stage1-vs-Stage4 |
5.051500E-02 |
| Stage2-vs-Stage3 |
1.536390E-01 |
| Stage2-vs-Stage4 |
3.400300E-02 |
| Stage3-vs-Stage4 |
2.603000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.47909479003761E-11 |
| Normal-vs-AfricanAmerican |
6.632500E-02 |
| Normal-vs-Asian |
6.723600E-02 |
| Caucasian-vs-AfricanAmerican |
6.738900E-03 |
| Caucasian-vs-Asian |
6.162600E-01 |
| AfricanAmerican-vs-Asian |
5.406000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.74279479736583E-11 |
| Normal-vs-Female |
4.6232999999507E-06 |
| Male-vs-Female |
2.068400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.401260E-03 |
| Normal-vs-Age(41-60Yrs) |
8.20799994638577E-09 |
| Normal-vs-Age(61-80Yrs) |
4.78320050234515E-10 |
| Normal-vs-Age(81-100Yrs) |
6.240600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.447000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.796800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.373930E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.506400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.192430E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.683990E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.789700E-02 |
| Normal-vs-Grade 2 |
1.01729957791008E-10 |
| Normal-vs-Grade 3 |
1.1709999999665E-06 |
| Normal-vs-Grade 4 |
7.45809999980196E-07 |
| Grade 1-vs-Grade 2 |
1.893760E-01 |
| Grade 1-vs-Grade 3 |
5.176000E-01 |
| Grade 1-vs-Grade 4 |
5.392400E-02 |
| Grade 2-vs-Grade 3 |
3.822100E-02 |
| Grade 2-vs-Grade 4 |
5.733600E-01 |
| Grade 3-vs-Grade 4 |
6.403800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.67210000027119E-07 |
| Normal-vs-ccB subtype |
1.07579500863153E-11 |
| ccA subtype-vs-ccB subtype |
1.858290E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.34680000485332E-09 |
| Normal-vs-N1 |
3.083100E-03 |
| N0-vs-N1 |
2.497400E-01 |
|
|
